Ensuring your healthcare team provides clear information: No One Missed (Episode 10)

In this episode of the No One Missed: Biomarker Testing in MBC series, Dr. Mehta, MD, of MD Anderson Cancer Center, talks with patient advocate and podcast host, Jenny Burkholder and clarifies the differences between genetic and genomic testing for metastatic breast cancer patients. He discusses why it’s important for patients to ask their oncologist about these tests and offers tips on how to ensure your questions are answered, while highlighting key aspects of both testing types.
About the No One Missed: Biomarker Testing in MBC series:
In this 10-episode video series, Jenny Burkholder, a metastatic breast cancer patient advocate and podcaster, sits down with Dr. Pallav Mehta, to discuss the importance of biomarker testing in metastatic breast cancer, including the science behind the powerful tool, and how it can improve patient outcomes.
Get the facts on biomarker testing for metastatic breast cancer and access resources to talk with your doctor about how this tool can help ensure you or your loved one's treatment plan is as effective as possible for metastatic breast cancer at: no1missed.org/...
For more information from Living Beyond Breast Cancer about biomarker testing, visit: www.lbbc.org/a...
About the Video Series Hosts:
Jenny Burkholder is a metastatic breast cancer patient advocate and co-host of OVERexpressed & OUT podcast
Dr. Pallav Mehta, MD, is an Assistant Professor of Medicine, MD Anderson Cancer Center at Cooper and Medical Director at Reimagine Care
#metastaticbreastcancer #MBC #breastcancer #biomarkertesting #biomarkers